A
JAZZ icon

Allianz’s Jazz Pharmaceuticals JAZZ Stock Holding History

Allianz’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$946K Buy
+3,926
New +$860K 0.01% 300
2025
Q4 		– Sell
-11,250
Closed -$1.48M – 443
2025
Q3 		$1.48M Buy
11,250
+30
+0.3% +$3.6K 0.03% 209
2025
Q2 		$1.19M Buy
11,220
+10,984
+4,654% +$1.19M 0.03% 210
2025
Q1 		$29.3K Hold
236
– – ﹤0.01% 370
2024
Q4 		$29K Sell
236
-314
-57% -$37K ﹤0.01% 383
2024
Q3 		$61.3K Sell
550
-380
-41% -$41.6K ﹤0.01% 342
2024
Q2 		$99.3K Hold
930
– – ﹤0.01% 370
2024
Q1 		$112K Buy
+930
New +$114K ﹤0.01% 360

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Allianz's JAZZ Position: Q2 2026 in Review

Allianz opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 3,926 shares worth $946K. The stake represents 0.01% of the portfolio and ranks #300 among its holdings. This is a return to the name: Allianz previously reported a position in JAZZ as recently as Q3 2025.

Allianz first reported a position in JAZZ in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.48M in Q3 2025. 643 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Allianz held 3,926 shares of Jazz Pharmaceuticals worth $946K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Allianz position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Allianz's portfolio in Q2 2026, its #300 holding.
  • Allianz first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Allianz's Jazz Pharmaceuticals position peaked at $1.48M in Q3 2025.
  • 643 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.